| UniProt ID | RC3H2_HUMAN | |
|---|---|---|
| UniProt AC | Q9HBD1 | |
| Protein Name | Roquin-2 | |
| Gene Name | RC3H2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1191 | |
| Subcellular Localization | Cytoplasm, P-body. During stress, such as that induced by arsenite, localizes to cytosolic stress granules. Localization to stress granules, but not to P-bodies, depends upon the RING-type zinc finger. | |
| Protein Description | Post-transcriptional repressor of mRNAs containing a conserved stem loop motif, called constitutive decay element (CDE), which is often located in the 3'-UTR, as in HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF and in many more mRNAs. Binds to CDE and promotes mRNA deadenylation and degradation. This process does not involve miRNAs. In follicular helper T (Tfh) cells, represses of ICOS and TNFRSF4 expression, thus preventing spontaneous Tfh cell differentiation, germinal center B-cell differentiation in the absence of immunization and autoimmunity. In resting or LPS-stimulated macrophages, controls inflammation by suppressing TNF expression. Also recognizes CDE in its own mRNA and in that of paralogous RC3H1, possibly leading to feedback loop regulation (By similarity). miRNA-binding protein that regulates microRNA homeostasis. Enhances DICER-mediated processing of pre-MIR146a but reduces mature MIR146a levels through an increase of 3' end uridylation. Both inhibits ICOS mRNA expression and they may act together to exert the suppression. [PubMed: 25697406 Acts as a ubiquitin E3 ligase. Pairs with E2 enzymes UBE2B, UBE2D2, UBE2E2, UBE2E3, UBE2G2, UBE2K and UBE2Q2 and produces polyubiquitin chains] | |
| Protein Sequence | MPVQAAQWTEFLSCPICYNEFDENVHKPISLGCSHTVCKTCLNKLHRKACPFDQTAINTDIDVLPVNFALLQLVGAQVPDHQSIKLSNLGENKHYEVAKKCVEDLALYLKPLSGGKGVASLNQSALSRPMQRKLVTLVNCQLVEEEGRVRAMRAARSLGERTVTELILQHQNPQQLSANLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRSYEALRREHDAQIVHIAMEAGLRISPEQWSSLLYGDLAHKSHMQSIIDKLQSPESFAKSVQELTIVLQRTGDPANLNRLRPHLELLANIDPNPDAVSPTWEQLENAMVAVKTVVHGLVDFIQNYSRKGHETPQPQPNSKYKTSMCRDLRQQGGCPRGTNCTFAHSQEELEKYRLRNKKINATVRTFPLLNKVGVNNTVTTTAGNVISVIGSTETTGKIVPSTNGISNAENSVSQLISRSTDSTLRALETVKKVGKVGANGQNAAGPSADSVTENKIGSPPKTPVSNVAATSAGPSNVGTELNSVPQKSSPFLTRVPVYPPHSENIQYFQDPRTQIPFEVPQYPQTGYYPPPPTVPAGVAPCVPRFVRSNNVPESSLPPASMPYADHYSTFSPRDRMNSSPYQPPPPQPYGPVPPVPSGMYAPVYDSRRIWRPPMYQRDDIIRSNSLPPMDVMHSSVYQTSLRERYNSLDGYYSVACQPPSEPRTTVPLPREPCGHLKTSCEEQIRRKPDQWAQYHTQKAPLVSSTLPVATQSPTPPSPLFSVDFRADFSESVSGTKFEEDHLSHYSPWSCGTIGSCINAIDSEPKDVIANSNAVLMDLDSGDVKRRVHLFETQRRTKEEDPIIPFSDGPIISKWGAISRSSRTGYHTTDPVQATASQGSATKPISVSDYVPYVNAVDSRWSSYGNEATSSAHYVERDRFIVTDLSGHRKHSSTGDLLSLELQQAKSNSLLLQREANALAMQQKWNSLDEGRHLTLNLLSKEIELRNGELQSDYTEDATDTKPDRDIELELSALDTDEPDGQSEPIEEILDIQLGISSQNDQLLNGMAVENGHPVQQHQKEPPKQKKQSLGEDHVILEEQKTILPVTSCFSQPLPVSISNASCLPITTSVSAGNLILKTHVMSEDKNDFLKPVANGKMVNS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 120 | Phosphorylation | SGGKGVASLNQSALS CCCCCHHHCCHHHHC | 26.00 | 24719451 | |
| 212 | Phosphorylation | LLALEDGSALSRKVL HHHHCCCCHHHHHHH | 38.06 | 23403867 | |
| 215 | Phosphorylation | LEDGSALSRKVLVLF HCCCCHHHHHHHHHH | 29.76 | 23403867 | |
| 250 | Phosphorylation | VQLLYRASCFKVTKR HHHHHHHHCEECEEC | 15.87 | 19413330 | |
| 453 | Phosphorylation | RNKKINATVRTFPLL HCCCCCCEEECHHCC | 13.16 | 20363803 | |
| 471 | O-linked_Glycosylation | GVNNTVTTTAGNVIS CCCCCEEECCCCEEE | 15.43 | 30059200 | |
| 472 | O-linked_Glycosylation | VNNTVTTTAGNVISV CCCCEEECCCCEEEE | 24.17 | 30059200 | |
| 497 | O-linked_Glycosylation | VPSTNGISNAENSVS CCCCCCCCCCCHHHH | 31.24 | 30059200 | |
| 514 | Phosphorylation | ISRSTDSTLRALETV HHCCHHHHHHHHHHH | 24.07 | - | |
| 549 | Phosphorylation | VTENKIGSPPKTPVS CCCCCCCCCCCCCCC | 41.31 | 25159151 | |
| 553 | Phosphorylation | KIGSPPKTPVSNVAA CCCCCCCCCCCCCCC | 34.40 | 25159151 | |
| 556 | Phosphorylation | SPPKTPVSNVAATSA CCCCCCCCCCCCCCC | 27.13 | 23927012 | |
| 561 | Phosphorylation | PVSNVAATSAGPSNV CCCCCCCCCCCCCCC | 14.90 | 23927012 | |
| 562 | Phosphorylation | VSNVAATSAGPSNVG CCCCCCCCCCCCCCC | 26.88 | 23403867 | |
| 566 | Phosphorylation | AATSAGPSNVGTELN CCCCCCCCCCCCCCC | 43.14 | 23403867 | |
| 579 | Phosphorylation | LNSVPQKSSPFLTRV CCCCCCCCCCCEECC | 37.69 | 27251275 | |
| 580 | Phosphorylation | NSVPQKSSPFLTRVP CCCCCCCCCCEECCC | 27.06 | 21815630 | |
| 584 | Phosphorylation | QKSSPFLTRVPVYPP CCCCCCEECCCCCCC | 29.96 | 24719451 | |
| 593 | O-linked_Glycosylation | VPVYPPHSENIQYFQ CCCCCCCCCCCCCCC | 37.80 | 30059200 | |
| 662 | Phosphorylation | ADHYSTFSPRDRMNS CCCCCCCCCCCCCCC | 21.08 | 24719451 | |
| 666 | Methylation | STFSPRDRMNSSPYQ CCCCCCCCCCCCCCC | 27.71 | 30762627 | |
| 666 | Dimethylation | STFSPRDRMNSSPYQ CCCCCCCCCCCCCCC | 27.71 | - | |
| 669 | Phosphorylation | SPRDRMNSSPYQPPP CCCCCCCCCCCCCCC | 24.28 | 28555341 | |
| 670 | Phosphorylation | PRDRMNSSPYQPPPP CCCCCCCCCCCCCCC | 23.71 | 28555341 | |
| 691 | Phosphorylation | PPVPSGMYAPVYDSR CCCCCCCCCCCCCCC | 15.98 | - | |
| 714 | Phosphorylation | QRDDIIRSNSLPPMD CCCHHHHCCCCCCHH | 21.99 | 28348404 | |
| 716 | Phosphorylation | DDIIRSNSLPPMDVM CHHHHCCCCCCHHHC | 43.42 | 28348404 | |
| 726 | O-linked_Glycosylation | PMDVMHSSVYQTSLR CHHHCCCHHHHHHHH | 15.34 | 30059200 | |
| 736 | Phosphorylation | QTSLRERYNSLDGYY HHHHHHHHHHCCCEE | 12.35 | 29978859 | |
| 738 | Phosphorylation | SLRERYNSLDGYYSV HHHHHHHHCCCEEEE | 20.92 | 29978859 | |
| 742 | Phosphorylation | RYNSLDGYYSVACQP HHHHCCCEEEEEECC | 7.70 | 27642862 | |
| 743 | Phosphorylation | YNSLDGYYSVACQPP HHHCCCEEEEEECCC | 11.38 | 27642862 | |
| 755 | O-linked_Glycosylation | QPPSEPRTTVPLPRE CCCCCCCCCCCCCCC | 42.75 | 30059200 | |
| 768 | Methylation | REPCGHLKTSCEEQI CCCCCCCCCCHHHHH | 32.49 | 115973179 | |
| 778 | Ubiquitination | CEEQIRRKPDQWAQY HHHHHHHCHHHHHHH | 43.00 | - | |
| 794 | Phosphorylation | TQKAPLVSSTLPVAT HCCCCCEECCCCCCC | 25.86 | 27732954 | |
| 795 | Phosphorylation | QKAPLVSSTLPVATQ CCCCCEECCCCCCCC | 26.87 | 27732954 | |
| 796 | Phosphorylation | KAPLVSSTLPVATQS CCCCEECCCCCCCCC | 27.81 | 27732954 | |
| 801 | Phosphorylation | SSTLPVATQSPTPPS ECCCCCCCCCCCCCC | 29.79 | 29255136 | |
| 803 | Phosphorylation | TLPVATQSPTPPSPL CCCCCCCCCCCCCCC | 26.79 | 29255136 | |
| 805 | Phosphorylation | PVATQSPTPPSPLFS CCCCCCCCCCCCCEE | 53.75 | 29255136 | |
| 808 | Phosphorylation | TQSPTPPSPLFSVDF CCCCCCCCCCEEEEE | 35.12 | 29255136 | |
| 812 | Phosphorylation | TPPSPLFSVDFRADF CCCCCCEEEEEECCC | 28.58 | 29255136 | |
| 834 | Phosphorylation | KFEEDHLSHYSPWSC CCCCCCHHHCCCCCC | 19.57 | 25627689 | |
| 837 | Phosphorylation | EDHLSHYSPWSCGTI CCCHHHCCCCCCHHH | 17.92 | 25627689 | |
| 871 | Phosphorylation | AVLMDLDSGDVKRRV CEEEECCCCCHHHHE | 44.16 | 24719451 | |
| 875 | Ubiquitination | DLDSGDVKRRVHLFE ECCCCCHHHHEEHHH | 38.95 | - | |
| 883 | O-linked_Glycosylation | RRVHLFETQRRTKEE HHEEHHHHCCCCCCC | 21.75 | 30059200 | |
| 887 | O-linked_Glycosylation | LFETQRRTKEEDPII HHHHCCCCCCCCCCC | 45.02 | 30059200 | |
| 888 | Ubiquitination | FETQRRTKEEDPIIP HHHCCCCCCCCCCCC | 58.24 | - | |
| 897 | O-linked_Glycosylation | EDPIIPFSDGPIISK CCCCCCCCCCCCEEC | 35.98 | 30059200 | |
| 903 | O-linked_Glycosylation | FSDGPIISKWGAISR CCCCCCEECCCCCCC | 24.07 | 30059200 | |
| 909 | O-linked_Glycosylation | ISKWGAISRSSRTGY EECCCCCCCCCCCCC | 26.10 | 30059200 | |
| 932 | Phosphorylation | TASQGSATKPISVSD CCCCCCCCCCCCHHH | 38.76 | 28555341 | |
| 954 | Phosphorylation | VDSRWSSYGNEATSS ECCCHHHCCCCCCCC | 20.60 | 29978859 | |
| 959 | Phosphorylation | SSYGNEATSSAHYVE HHCCCCCCCCCEEEE | 19.62 | 28796482 | |
| 960 | Phosphorylation | SYGNEATSSAHYVER HCCCCCCCCCEEEEC | 32.35 | 28796482 | |
| 960 | O-linked_Glycosylation | SYGNEATSSAHYVER HCCCCCCCCCEEEEC | 32.35 | 30059200 | |
| 961 | Phosphorylation | YGNEATSSAHYVERD CCCCCCCCCEEEECC | 18.08 | 28796482 | |
| 964 | Phosphorylation | EATSSAHYVERDRFI CCCCCCEEEECCEEE | 12.06 | 28796482 | |
| 976 | Phosphorylation | RFIVTDLSGHRKHSS EEEEECCCCCCCCCC | 35.05 | 28555341 | |
| 982 | Phosphorylation | LSGHRKHSSTGDLLS CCCCCCCCCCCCHHH | 32.41 | 23401153 | |
| 983 | Phosphorylation | SGHRKHSSTGDLLSL CCCCCCCCCCCHHHH | 35.81 | 23927012 | |
| 984 | Phosphorylation | GHRKHSSTGDLLSLE CCCCCCCCCCHHHHH | 37.42 | 25159151 | |
| 989 | Phosphorylation | SSTGDLLSLELQQAK CCCCCHHHHHHHHHH | 27.39 | 23403867 | |
| 996 | Ubiquitination | SLELQQAKSNSLLLQ HHHHHHHHCCCHHHH | 45.92 | - | |
| 999 | Phosphorylation | LQQAKSNSLLLQREA HHHHHCCCHHHHHHH | 27.73 | 22985185 | |
| 1014 | Ubiquitination | NALAMQQKWNSLDEG HHHHHHHHHHHCHHC | 31.30 | - | |
| 1017 | Phosphorylation | AMQQKWNSLDEGRHL HHHHHHHHCHHCHHH | 35.76 | 21815630 | |
| 1030 | Phosphorylation | HLTLNLLSKEIELRN HHHHHHHHHHHHHHC | 31.26 | 28555341 | |
| 1031 | Ubiquitination | LTLNLLSKEIELRNG HHHHHHHHHHHHHCC | 63.78 | - | |
| 1044 | Phosphorylation | NGELQSDYTEDATDT CCCCCCCCCCCCCCC | 19.78 | 27642862 | |
| 1119 | Phosphorylation | PPKQKKQSLGEDHVI CCHHHCCCCCCCCEE | 47.42 | 29255136 | |
| 1168 | Ubiquitination | SAGNLILKTHVMSED CCCCEEEEEECCCCC | 29.59 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RC3H2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RC3H2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRIM8_HUMAN | TRIM8 | physical | 22493164 | |
| RC3H2_HUMAN | RC3H2 | physical | 26489670 | |
| UBC_HUMAN | UBC | physical | 26489670 | |
| UB2E2_HUMAN | UBE2E2 | physical | 26489670 | |
| UB2E3_HUMAN | UBE2E3 | physical | 26489670 | |
| UBE2K_HUMAN | UBE2K | physical | 26489670 | |
| UB2Q2_HUMAN | UBE2Q2 | physical | 26489670 | |
| UBE2B_HUMAN | UBE2B | physical | 26489670 | |
| UB2D2_HUMAN | UBE2D2 | physical | 26489670 | |
| UB2G2_HUMAN | UBE2G2 | physical | 26489670 | |
| UBE2N_HUMAN | UBE2N | physical | 26489670 | |
| UB2V1_HUMAN | UBE2V1 | physical | 26489670 | |
| UB2V2_HUMAN | UBE2V2 | physical | 26489670 | |
| CP19A_HUMAN | CYP19A1 | physical | 28514442 | |
| ACTBL_HUMAN | ACTBL2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549, AND MASSSPECTROMETRY. | |